Drug Shortage Report for FOLIC ACID INJECTION, USP
Report ID | 152914 |
Drug Identification Number | 02139480 |
Brand name | FOLIC ACID INJECTION, USP |
Common or Proper name | FOLIC ACID INJECTION |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | FOLIC ACID |
Strength(s) | 5MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
Packaging size | 1 |
ATC code | B03BB |
ATC description | VITAMIN B12 AND FOLIC ACID |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2022-01-14 |
Actual start date | 2022-01-14 |
Estimated end date | 2022-01-20 |
Actual end date | 2022-01-20 |
Shortage status | Resolved |
Updated date | 2022-01-21 |
Company comments | Fresenius Kabi Canada regrets to advise that due to a shipping delay, we will be encountering a supply interruption on our Folic Acid for Injection 5mg/mL Vial 10mL effective today, January 14, 2022 until January 20, 2022. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2022-01-21 | French | Compare |
v3 | 2022-01-21 | English | Compare |
v2 | 2022-01-17 | French | Compare |
v1 | 2022-01-17 | English | Compare |
Showing 1 to 4 of 4